Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

NCT01173731 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Parkinson Disease
Dyskinesia, Drug-Induced
Levodopa

Interventions

DRUG: AFQ056

Sponsor

Novartis Pharmaceuticals